Privi Speciality Chemicals has informed that a meeting of the Equity Shareholders of the Company was held on Tuesday, October 27, 2026 at 12:30 pm at deemed venue for the purpose of considering, and if thought fit, approving the proposed Scheme of Amalgamation of Privi Fine Sciences Private Limited, the Transferor Company 1 and Privi Biotechnologies Private Limited, the Transferor Company 2 with Privi Speciality Chemicals Limited, the Transferee Company ('Scheme') under sections 230 to 232 and other applicable provisions of the Companies Act, 2013 ('Act') along with the Companies (Compromises, Arrangements and Amalgamations) Rules, 2016 ('Merger Rules') and other applicable rules under the Act.
The above information is a part of company’s filings submitted to BSE.